Hunt Medical Ltd 13946908 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 13946908 2024-04-01 2025-03-31 13946908 2025-03-31 13946908 core:RetainedEarningsAccumulatedLosses 2025-03-31 13946908 core:ShareCapital 2025-03-31 13946908 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 13946908 bus:SmallEntities 2024-04-01 2025-03-31 13946908 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13946908 bus:FullAccounts 2024-04-01 2025-03-31 13946908 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13946908 bus:RegisteredOffice 2024-04-01 2025-03-31 13946908 bus:Director1 2024-04-01 2025-03-31 13946908 bus:Director1 1 2024-04-01 2025-03-31 13946908 bus:Director2 2024-04-01 2025-03-31 13946908 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13946908 core:OfficeEquipment 2024-04-01 2025-03-31 13946908 countries:England 2024-04-01 2025-03-31 13946908 2023-04-01 2024-03-31 13946908 2024-03-31 13946908 core:RetainedEarningsAccumulatedLosses 2024-03-31 13946908 core:ShareCapital 2024-03-31 13946908 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 13946908

Hunt Medical Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2025

 

Hunt Medical Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Hunt Medical Ltd

(Registration number: 13946908)
Abridged Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

636

-

Current assets

 

Debtors

2,969

5,056

Cash at bank and in hand

 

3,522

534

 

6,491

5,590

Creditors: Amounts falling due within one year

(5,612)

(5,580)

Net current assets

 

879

10

Net assets

 

1,515

10

Capital and reserves

 

Called up share capital

95

95

Profit and loss account

1,420

(85)

Total equity

 

1,515

10

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 12 August 2025 and signed on its behalf by:
 

Dr J A Hunt

Director

Mrs E Hunt

Director

 

Hunt Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 12 August 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Hunt Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

15% reducing balance

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 1).

4

Tangible assets

Total
£

Cost or valuation

Additions

748

At 31 March 2025

748

Depreciation

Charge for the year

112

At 31 March 2025

112

Carrying amount

At 31 March 2025

636

5

Related party transactions

Advances to directors


Dr J A Hunt

During the period Dr J A Hunt went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £(1,885) (2024 - £(868)). At the year end the amount outstanding from Dr J A Hunt was £(2,969) (2024 - £(1,856)). Interest has been charged at the commercial rate.